Wird geladen...
Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD(65)-induced immune response
AIMS/HYPOTHESIS: A European Phase III trial of GAD formulated with aluminium hydroxide (GAD-alum) failed to reach its primary endpoint (preservation of stimulated C-peptide secretion from baseline to 15 months in type 1 diabetes patients), but subgroup analysis showed a clinical effect when particip...
Gespeichert in:
| Veröffentlicht in: | Diabetologia |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer Berlin Heidelberg
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5487599/ https://ncbi.nlm.nih.gov/pubmed/28357504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-017-4263-x |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|